deoxycytidine has been researched along with Leukemia L 1210 in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 49 (69.01) | 18.7374 |
1990's | 17 (23.94) | 18.2507 |
2000's | 4 (5.63) | 29.6817 |
2010's | 1 (1.41) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cook, PD; McNamara, DJ | 1 |
Bloomer, LC; Patil, VD; Townsend, LB; Wise, DS; Wotring, LL | 1 |
Avery, TL; Chwang, TL; Fridland, A | 1 |
Baze, WB; Cui, Z; Finch, RA; Jolly, CA; Naguib, YW; Valdes, S | 1 |
Arias, JL; Couvreur, P; Reddy, LH | 1 |
Cros, E; Dumontet, C; Galmarini, CM; Gouy, MH; Jordheim, LP; Mackey, J; Perigaud, C; Peyrottes, S | 1 |
Cory, AH; Cory, JG | 1 |
Couvreur, P; Desmaele, D; Dubernet, C; Marque, PE; Mouelhi, SL; Reddy, LH | 1 |
Durkacz, BW; Gray, DA; Shall, S | 1 |
Balzarini, J; De Clercq, E; Duggan, MJ; Dyer, RL; Jones, AS; Rahim, SG; Walker, RT | 1 |
Balzarini, J; De Clercq, E | 3 |
Bacon, PE; Chiba, P; Cory, JG | 1 |
Balzarini, J; Buchele, A; De Clercq, E; Keppeler, K; Kiefer, G | 1 |
Boothman, DA; Greer, S; Mekras, JA; Perez, LM | 1 |
Covey, JM; Zaharko, DS | 1 |
Samuels, LL; Straw, JA | 1 |
Cory, JG; Montgomery, JA; Sato, A | 1 |
Lin, TS; Mancini, WR | 1 |
Gao, YS; Lin, TS; Mancini, WR | 1 |
Balzarini, J; De Clercq, E; Hunston, RN; Jones, AS; McGuigan, C; Walker, RT | 1 |
Cysyk, RL; Hoerauf, RM; Karle, JM | 1 |
Ramonas, LM; Zaharko, DS | 1 |
Braun, TJ; Burchenal, JH; Chou, TC; Fox, JJ; Philips, FS; Schmid, FA; Su, TL; Watanabe, KA | 1 |
Katz, DJ; Townsend, LB; Wise, DS | 1 |
Balzarini, J; Bergstrom, DE; De Clercq, E; Descamps, J; Huang, GF; Jones, AS; Serafinowski, P; Torrence, PF; Verhelst, G; Walker, RT | 1 |
Cadman, E; Grant, S; Lehman, C | 1 |
Kalman, TI; Kerr, SG | 1 |
Dan, A; Matsuda, A; Minakawa, N; Okazaki, S; Sasaki, T; Sugimoto, Y; Tregear, SJ | 1 |
Cory, AH; Cory, JG; Robins, MJ; Samano, V | 1 |
Cory, AH; Cory, JG; Hertel, LW; Kroin, JS | 1 |
Chalovich, JM; Cory, AH; Cory, JG; Shibley, IA | 1 |
Tsukagoshi, S | 1 |
Cory, AH; Cory, JG; Nelson, TO; Somerville, L | 1 |
Gowans, B; Hunting, DJ; Tremblay, S; Wagner, JR | 1 |
Marańda, E; Robak, T | 1 |
Bergman, AM; Brouwer, M; Eriksson, S; Jongsma, AP; Leyva, A; Peters, GJ; Pinedo, HM; Ruiz van Haperen, VW; Veerman, G | 1 |
Marañda, E; Robak, T; Szmigielska, A | 1 |
Schreiber, C; Waxman, S | 1 |
Buchman, VM; Lichinitser, MR; Mkheidze, DM; Svet-Moldavsky, GJ | 1 |
Abbasi, MM; Beisler, JA; Voytek, P; Wolpert-DeFilippes, MK | 1 |
Cihák, A; Veselý, J | 1 |
Gonzales, FA; Momparier, RL | 1 |
Brockman, RW; Nelson, JA; Rose, LM; Schabel, FM; Shaddix, SC; Williams, M | 1 |
Bukhman, VM; Lichinitser, MR; Mkheidze, DM; Svet-Moldavskiĭ, GIa | 1 |
Momparler, LF; Momparler, RL; Rivard, GE; Veselý, J | 1 |
Barkhotkina, MF; Belyanchikova, NI; Buchman, VM; Lichinitser, MR; Litovchenko, TA; Mkheidze, DM; Svet-Moldavsky, GJ | 1 |
Buchman, VM; Lichinitser, MR; Mkheidze, DM; Svet-Maoldavsky, GJ | 1 |
Baguley, BC; Falkenhaug, EM | 1 |
Chou, TC; Hutchison, DJ; Philips, FS; Schmid, FA | 1 |
Harrap, KR; Mulder, JH | 1 |
Mancini, WR | 1 |
Montgomery, JA; Riordan, JM; Secrist, JA; Tiwari, KN | 1 |
Birnbaum, GI; Cheng, YC; Clarke-Katzenburg, RH; Gabe, EJ; Giziewicz, J; Lin, TS; Liu, MC; Luo, MZ; Mancini, WR; Prusoff, WH | 1 |
Matsuda, A; Sasaki, T; Takenuki, K; Ueda, T | 1 |
Matsuda, A; Sasaki, T; Takenuki, K; Tanaka, M; Ueda, T | 1 |
Boder, GB; Grindey, GB; Hertel, LW; Kroin, JS; Poore, GA; Rinzel, SM; Todd, GC | 1 |
Veselý, J | 1 |
Balzarini, J; Broder, S; Cooney, DA; Cupp, JE; Dalal, M; DeClercq, E; Johns, DG; Kang, GJ | 1 |
Danenberg, PV; Ibric, LL; Peterson, AR; Peterson, H | 1 |
Kalman, TI; Yalowich, JC | 1 |
Itoh, H; Matsuda, A; Sasaki, T; Takenuki, K; Ueda, T | 1 |
Cory, JG; Weckbecker, G | 1 |
Bergstrom, D; Kahilainen, L; Kangas, L; Vilpo, JA | 1 |
Lin, TS; Prusoff, WH | 1 |
Cory, JG; Ohmstede, CA | 1 |
Balzarini, J | 1 |
Jato, J; Windheuser, JJ | 1 |
Bloch, A; McPartland, RP; Wang, MC; Weinfeld, H | 1 |
Bloch, A; Sharma, RA; Wang, MC | 1 |
2 review(s) available for deoxycytidine and Leukemia L 1210
Article | Year |
---|---|
[Development of antimetabolites, II].
Topics: Aminopterin; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cytarabine; Deoxycytidine; Humans; Leukemia L1210; Methotrexate; Mice; Trimetrexate | 1993 |
Deoxyribonucleoside-induced selective modulation of cytotoxicity and mutagenesis.
Topics: Alkylating Agents; Animals; Azaguanine; Cell Line; Cell Survival; Cricetinae; Deoxyadenosines; Deoxycytidine; Deoxycytosine Nucleotides; Deoxyguanosine; Deoxyribonucleosides; DNA; Drug Resistance; Drug Synergism; Floxuridine; Leukemia L1210; Lung; Methylation; Methylnitronitrosoguanidine; Mice; Mutagens; Mutation; Thymidine; Thymidylate Synthase; Thymine Nucleotides | 1985 |
69 other study(ies) available for deoxycytidine and Leukemia L 1210
Article | Year |
---|---|
Synthesis and antitumor activity of fluorine-substituted 4-amino-2(1H)-pyridinones and their nucleosides. 3-Deazacytosines.
Topics: Animals; Antimetabolites, Antineoplastic; Cytosine; Drug Evaluation, Preclinical; Indicators and Reagents; Leukemia L1210; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Spectrophotometry; Structure-Activity Relationship | 1987 |
Synthesis and biological activity of a novel adenosine analogue, 3-beta-D-ribofuranosylthieno[2,3-d]pyrimidin-4-one.
Topics: Adenosine; Adenosine Kinase; Animals; Antineoplastic Agents; Biotransformation; In Vitro Techniques; Leukemia L1210; Mice; Pyrimidine Nucleosides | 1985 |
2'-O-nitro-1-beta-D-arabinofuranosylcytosine. A new derivative of 1-beta-D-arabinofuranosylcytosine that resists enzymatic deamination and has antileukemic activity.
Topics: Animals; Antimetabolites, Antineoplastic; Cytarabine; Drug Evaluation, Preclinical; Female; Leukemia L1210; Mice; Mice, Inbred Strains | 1983 |
Preclinical Evaluation of the Short-Term Toxicity of 4-(N)-Docosahexaenoyl 2´, 2´- Difluorodeoxycytidine (DHA-dFdC).
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Deoxycytidine; Drug Compounding; Female; Gemcitabine; Humans; Leukemia L1210; Maximum Tolerated Dose; Mice, Inbred DBA | 2017 |
Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine.
Topics: Animals; Antimetabolites, Antineoplastic; Cyanoacrylates; Deoxycytidine; Drug Carriers; Gemcitabine; Hydrogen-Ion Concentration; Injections, Intravenous; Leukemia L1210; Mice; Mice, Inbred DBA; Nanoparticles; Polymers | 2009 |
Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug.
Topics: Animals; Antimetabolites, Antineoplastic; Base Sequence; Cell Survival; Deoxycytidine; Disease Models, Animal; DNA Primers; Drug Resistance, Neoplasm; Gemcitabine; Gene Expression Regulation, Neoplastic; Kinetics; Leukemia L1210; Mice; Polymerase Chain Reaction; Time Factors | 2004 |
Gemcitabine-induced apoptosis in a drug-resistant mouse leukemia L1210 cell line that does not express p53.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Deoxyadenosines; Deoxycytidine; Drug Resistance, Neoplasm; Flavonoids; Gemcitabine; Leukemia L1210; Methotrexate; Mice; Piperidines; Tumor Suppressor Protein p53 | 2004 |
A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Resistance, Neoplasm; Humans; Leukemia L1210; Mice; Mice, Inbred DBA; Molecular Structure; Nanomedicine; Nanoparticles; Squalene; Tissue Distribution | 2007 |
Inhibitors of nuclear ADP-ribosyl transferase retard DNA repair after N-methyl-N-nitroso-urea. Further evidence for the involvement of (ADP-ribose)n in DNA repair.
Topics: Adenosine Diphosphate Ribose; Animals; Cell Division; Centrifugation, Density Gradient; Deoxycytidine; DNA Repair; Leukemia L1210; Methylnitrosourea; Mice; Niacinamide; Nitrosourea Compounds; Nucleoside Diphosphate Sugars; Nucleotidyltransferases; Poly(ADP-ribose) Polymerases; Thymidine | 1981 |
Synthesis and biological properties of 2'-deoxy-5-vinyluridine and 2'deoxy-5-vinylcytidine.
Topics: Animals; Antiviral Agents; Deoxycytidine; Deoxyuridine; Drug Evaluation, Preclinical; Herpesviridae Infections; Leukemia L1210; Mice; Structure-Activity Relationship | 1982 |
Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
Topics: Animals; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Cell Division; Cytarabine; Deoxycytidine; Deoxycytidine Kinase; DNA, Neoplasm; Leukemia L1210; Mice; Phosphotransferases; Thymidine Kinase | 1983 |
Studies directed toward testing the "channeling" hypothesis--ribonucleotides----DNA in leukemia L1210 cells.
Topics: Animals; Aphidicolin; Cytidine; Deoxycytidine; Diterpenes; DNA Replication; Hydroxyurea; Leukemia L1210; Mice; Multienzyme Complexes; Nucleic Acid Synthesis Inhibitors; Ribonucleotide Reductases; Ribonucleotides; Thymidylate Synthase | 1984 |
Antitumor cell and antimetabolic effects of 5-ethyl-2'-deoxyuridine and 5'-substituted 5-ethyl-2'-deoxyuridine derivatives.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Division; Cell Survival; Cells, Cultured; Deoxycytidine; Deoxyuridine; DNA, Neoplasm; Leukemia L1210; Mice; Thymidine Kinase | 1984 |
Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Carcinoma, Squamous Cell; Cell Line; Cell Survival; Cricetinae; Cricetulus; DCMP Deaminase; Deoxycytidine; DNA Replication; Drug Evaluation, Preclinical; Female; Humans; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Nucleotide Deaminases; Ovary; Tetrahydrouridine; Uridine | 1984 |
Modulation of deoxycytidine metabolism in vivo with high-dose thymidine in mice.
Topics: Animals; Bone Marrow; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Deoxycytidine; DNA, Neoplasm; Duodenum; Half-Life; Kinetics; Leukemia L1210; Mice; Mice, Inbred Strains; Spleen; Thymidine | 1983 |
Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
Topics: Animals; Brain Neoplasms; Deoxycytidine; DNA Replication; Dose-Response Relationship, Drug; Hypoxanthine; Hypoxanthines; Inosine; Leucovorin; Leukemia L1210; Methotrexate; Mice; Thymidine; Thymine | 1984 |
Synergistic inhibition of leukemia L1210 cell growth in vitro by combinations of 2-fluoroadenine nucleosides and hydroxyurea or 2,3-dihydro-1H-pyrazole[2,3-a]imidazole.
Topics: Animals; Cell Survival; Cytidine; Deferoxamine; Deoxyadenosines; Deoxycytidine; Drug Synergism; Hydroxyurea; Kinetics; Leukemia L1210; Mice; Pyrazoles; Vidarabine | 1984 |
Ribo- and deoxyribonucleoside effect on 3'-amino-2',3'-dideoxycytidine-induced cytotoxicity in cultured L1210 cells.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; Cytarabine; Deamination; Deoxycytidine; Deoxyribonucleosides; DNA, Neoplasm; Leukemia L1210; Ribonucleosides; Zalcitabine | 1983 |
Synthesis and biological activity of various 3'-azido and 3'-amino analogues of 5-substituted pyrimidine deoxyribonucleosides.
Topics: Animals; Antineoplastic Agents; Deoxycytidine; Deoxycytidine Kinase; Deoxyuridine; Leukemia L1210; Mice; Sarcoma 180; Thymidine Kinase | 1983 |
Strategies for the measurement of the inhibitory effects of thymidine analogs on the activity of thymidylate synthase in intact murine leukemia L1210 cells.
Topics: Animals; Deoxycytidine; Deoxyuridine; DNA; Leukemia L1210; Methyltransferases; Mice; Thymidine; Thymidylate Synthase | 1984 |
Synthesis and biological properties of some cyclic phosphotriesters derived from 2'-deoxy-5-fluorouridine.
Topics: Animals; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Deoxycytidine; Deoxyuridine; Drug Resistance; Indicators and Reagents; Leukemia L1210; Mice; Organophosphorus Compounds; Structure-Activity Relationship; Thymidine; Thymidine Monophosphate | 1984 |
Labelling of the thymidine and deoxycytidine bases of DNA by [2-14C]deoxycytidine in cultured L1210 cells.
Topics: 3-Deazauridine; Animals; Carbon Radioisotopes; Cytarabine; Cytidine; Deoxycytidine; DNA; Leukemia L1210; Mice; Tetrahydrouridine; Thymidine | 1983 |
Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
Topics: Animals; Cell Survival; Chromatography, High Pressure Liquid; Clone Cells; Deoxycytidine; Dose-Response Relationship, Drug; Leukemia L1210; Mice; Mice, Inbred BALB C; Spleen; Thymidine; Time Factors | 1982 |
Biochemical effects of 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil and 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mouse leukemic cells sensitive and resistant to 1-beta-D-arabinofuranosylcytosine.
Topics: Animals; Arabinofuranosyluracil; Cell Survival; Cytarabine; Deoxycytidine; DNA Replication; Kinetics; Leukemia L1210; Leukemia, Experimental; Mice; Thymidine; Uridine | 1982 |
Synthesis of pyridazine analogues of the naturally occurring nucleosides cytidine, uridine, deoxycytidine, and deoxyuridine.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Cytidine; Deoxycytidine; Deoxyuridine; Hydrolysis; In Vitro Techniques; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Pyridazines; Pyrimidine Nucleosides; Uridine | 1982 |
Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
Topics: Animals; Antimetabolites, Antineoplastic; Antiviral Agents; Deoxycytidine; DNA, Neoplasm; Leukemia L1210; Mice; Time Factors | 1982 |
Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Cytarabine; Deoxycytidine; Deoxyribonucleotides; DNA, Neoplasm; Leukemia L1210; Mice; RNA, Neoplasm; Thymidine; Time Factors | 1980 |
N4-(dialkylamino)methylene derivatives of 2'-deoxycytidine and arabinocytidine: physicochemical studies for potential prodrug applications.
Topics: Animals; Chemical Phenomena; Chemistry, Physical; Cytarabine; Deoxycytidine; Drug Stability; Half-Life; Hydrolysis; Kinetics; Leukemia L1210; Lipids; Mice; Prodrugs; Solubility | 1994 |
Nucleosides and nucleotides. 123. Synthesis of 1-(2-deoxy-2-isocyano-beta-D-arabinofuranosyl)cytosine and related nucleosides as potential antitumor agents.
Topics: Animals; Antineoplastic Agents; Cytarabine; Deoxycytidine; Drug Stability; Humans; Isocyanates; Leukemia L1210; Lung Neoplasms; Mice; Molecular Structure; Mouth Neoplasms; Stomach Neoplasms; Thymine; Tumor Cells, Cultured; Uracil | 1993 |
2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture.
Topics: Animals; Cell Cycle; Cell Division; Deoxyadenosines; Deoxycytidine; Deoxyguanosine; Deoxyuridine; Leukemia L1210; Ribonucleotide Reductases; Tubercidin; Tumor Cells, Cultured | 1994 |
Effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on wild type and variant mouse leukemia L1210 cells.
Topics: Animals; Antimetabolites, Antineoplastic; Carbon Radioisotopes; Cytidine; Deoxycytidine; Gemcitabine; Leukemia L1210; Mice; Ribonucleotide Reductases; Tumor Cells, Cultured | 1993 |
Deoxyguanosine-resistant leukemia L1210 cells. Loss of specific deoxyribonucleoside kinase activity.
Topics: Animals; Antineoplastic Agents; Cell Division; Cytarabine; Deoxycytidine; Deoxyguanosine; Drug Resistance; Kinetics; Leukemia L1210; Mice; Nucleosides; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Tumor Cells, Cultured | 1993 |
Alterations in the properties of mouse leukemia L1210 cell lines selected by different methods for resistance to deoxyguanosine.
Topics: Animals; Cell Division; Cladribine; Cytarabine; Deoxycytidine; Deoxycytidine Kinase; Deoxyguanosine; Drug Resistance, Neoplasm; Kinetics; Leukemia L1210; Mice; Phosphotransferases (Alcohol Group Acceptor); Tumor Cells, Cultured | 1997 |
Incorporation of two deoxycytidine oxidation products into cellular DNA.
Topics: Animals; Deoxycytidine; Deoxyuridine; DNA; DNA Damage; DNA Repair; HeLa Cells; Humans; Jurkat Cells; Leukemia L1210; Mice; Oxidation-Reduction | 1997 |
Interactions of 2',2'-diflurodeoxycytidine (gemcitabine) with tumor necrosis factor alpha or its mutein VI in murine leukemias L1210 and P388.
Topics: Animals; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Interactions; Gemcitabine; Leukemia L1210; Leukemia P388; Male; Mice; Tumor Necrosis Factor-alpha | 1998 |
Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Division; Cytarabine; Cytidine Deaminase; Deoxycytidine; Deoxycytidine Kinase; DNA; Drug Resistance; Gemcitabine; Leukemia L1210; Mice; Nucleoside Deaminases; Polyphosphates; Rats; Rats, Inbred BN; Substrate Specificity; Thymidine Kinase; Tumor Cells, Cultured | 1999 |
Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Deoxycytidine; Drug Administration Schedule; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Leukemia L1210; Leukemia P388; Male; Mice | 1999 |
Varying effects of deoxynucleosides on the incorporation of thymidine into the DNA of monolayer and suspension cultures.
Topics: Animals; Ascites; Bone Marrow; Bone Marrow Cells; Cell Survival; Cells, Cultured; Deoxycytidine; Deoxyuridine; DNA; HeLa Cells; Hydrogen-Ion Concentration; Leukemia L1210; Lymphocytes; Neoplasms, Experimental; Thymidine | 1977 |
Deoxycytidine and lethal doses of cytarabine in advanced murine leukaemia.
Topics: Administration, Oral; Animals; Cytarabine; Deoxycytidine; Drug Antagonism; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mice | 1977 |
Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
Topics: Animals; Azacitidine; Cell Division; Cells, Cultured; Cytidine; Cytidine Deaminase; Deoxycytidine; Drug Synergism; Kinetics; Leukemia L1210; Oxidative Phosphorylation; Tetrahydrouridine; Thymidine; Uridine | 1977 |
Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice.
Topics: Animals; Azacitidine; Deoxycytidine; Epithelium; Female; Leukemia L1210; Leukemia, Experimental; Liver; Lymph Nodes; Mice; Mice, Inbred AKR; Mice, Inbred BALB C; Mice, Inbred DBA; Precancerous Conditions; Thymidine | 1977 |
Effect of intravenous infusion of 5-aza-2'-deoxycytidine on survival time of mice with L1210 leukemia.
Topics: Animals; Azacitidine; Cell Survival; Deoxycytidine; In Vitro Techniques; Infusions, Parenteral; Leukemia L1210; Male; Mice; Mice, Inbred Strains; Time Factors | 1978 |
The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
Topics: 3-Deazauridine; Adenocarcinoma; Animals; Cell Line; Cytarabine; Deoxycytidine; Deoxyribonucleotides; DNA, Neoplasm; Drug Resistance; Leukemia L1210; Liver; Mice; Neoplasms, Experimental; Orotic Acid; Phosphotransferases; Pyrimidine Nucleotides; Ribonucleotide Reductases; Ribonucleotides; RNA, Neoplasm; Uracil Nucleotides; Uridine | 1975 |
[Selective treatment of leukemia L1210 with combination of deoxycytidine and lethal doses of cytosine arabinoside].
Topics: Administration, Oral; Animals; Cytarabine; Deoxycytidine; Drug Evaluation; Drug Therapy, Combination; Injections, Intraperitoneal; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mice | 1978 |
Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
Topics: 3-Deazauridine; Animals; Cell Division; Cell Survival; Cells, Cultured; Deoxycytidine; DNA, Neoplasm; Drug Synergism; Leukemia L1210; Male; Mammary Neoplasms, Experimental; Mice; Uridine | 1979 |
2'-Deoxycytidine hydrochloride protection of mice against the lethal toxicity of cytosine arabinoside. Absence of protection of bone marrow lymphocytes.
Topics: Animals; Antibody Formation; Bone Marrow; Bone Marrow Cells; Cytarabine; Deoxycytidine; Female; Immunity, Cellular; Leukemia L1210; Lymphocytes; Male; Mice; Mice, Inbred Strains; Time Factors | 1979 |
Selective chemotherapy for advanced murine L 1210 leukemia by combination of 2' deoxycytidine and lethal doses of cytosine-arabinoside.
Topics: Animals; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Leukemia L1210; Male; Mice | 1977 |
Plasma half-life of cytosine arabinoside in patients with leukaemia--the effect of uridine.
Topics: Administration, Oral; Aminohydrolases; Animals; Cell Count; Cytarabine; Deoxycytidine; DNA, Neoplasm; Dose-Response Relationship, Drug; Half-Life; Humans; Leukemia L1210; Leukemia, Myeloid; Leukocytes; Mice; Uridine | 1975 |
Occurrence of deaminated monophosphate nucleotide in extracellular sites after giving arabinofuranosylcytosine or deoxycytidine to mice.
Topics: Animals; Blood Platelets; Cytarabine; Deoxycytidine; Intestine, Small; Leukemia L1210; Leukocytes; Liver; Mice; Myocardium; Nucleosides; Nucleotides; Spleen; Thymus Gland | 1975 |
Cytosine arabinoside uptake by tumour cells in vitro.
Topics: Animals; Cytarabine; Deoxycytidine; Diffusion; Female; In Vitro Techniques; Kinetics; Leukemia L1210; Leukemia, Experimental; Neoplasms, Experimental; Rats; Sarcoma, Yoshida | 1975 |
The role of deoxycytidine-metabolizing enzymes in the cytotoxicity induced by 3'-amino-2',3'-dideoxycytidine and cytosine arabinoside.
Topics: Animals; Antineoplastic Agents; Cell Count; Cell Division; Cytarabine; Cytidine Deaminase; Deoxycytidine; HeLa Cells; Humans; Leukemia L1210; Mice; Nucleoside Deaminases; Sensitivity and Specificity; Tumor Cells, Cultured; Zalcitabine | 1992 |
Synthesis and biological activity of 2'-deoxy-4'-thio pyrimidine nucleosides.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Cytomegalovirus; Deoxycytidine; Deoxyuridine; Humans; Leukemia L1210; Leukemia, T-Cell; Mice; Simplexvirus; Thionucleosides; Thiouridine; Thymidine; Tumor Cells, Cultured | 1991 |
Synthesis and anticancer and antiviral activities of various 2'- and 3'-methylidene-substituted nucleoside analogues and crystal structure of 2'-deoxy-2'-methylidenecytidine hydrochloride.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Chemical Phenomena; Chemistry; Crystallization; Cytarabine; Deoxycytidine; Female; Humans; Leukemia L1210; Leukemia P388; Leukemia, Lymphoid; Mice; Molecular Structure; Nucleosides; Sarcoma 180; Simplexvirus; Tumor Cells, Cultured; X-Ray Diffraction | 1991 |
Nucleosides and nucleotides. 94. Radical deoxygenation of tert-alcohols in 1-(2-C-alkylpentofuranosyl) pyrimidines: synthesis of (2'S)-2'-deoxy-2'-C-methylcytidine, an antileukemic nucleoside.
Topics: Animals; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Leukemia; Leukemia L1210; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Molecular Structure; Neoplasms; Structure-Activity Relationship | 1991 |
Nucleosides and nucleotides. 97. Synthesis of new broad spectrum antineoplastic nucleosides, 2'-deoxy-2'-methylidenecytidine (DMDC) and its derivatives.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Chemical Phenomena; Chemistry; Deoxycytidine; Female; Humans; Leukemia L1210; Mice; Structure-Activity Relationship | 1991 |
Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line; Cell Survival; Deoxycytidine; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Gemcitabine; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred ICR; Mice, Inbred Strains; Neoplasms, Experimental; Tumor Cells, Cultured | 1990 |
High degree of resistance to 5-aza-2'-deoxycytidine in L1210 cells in vitro associated with almost complete loss of deoxycytidine kinase activity.
Topics: 5-Methylcytosine; Animals; Azacitidine; Cell Line; Cells, Cultured; Cytosine; Decitabine; Deoxycytidine; Deoxycytidine Kinase; DNA (Cytosine-5-)-Methyltransferases; Drug Resistance; Leukemia L1210; Mice; Phosphorylation; Phosphotransferases | 1987 |
Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells.
Topics: Animals; Cells, Cultured; Deoxycytidine; Deoxycytidine Kinase; Leukemia L1210; Mice; Nucleic Acids; Phosphotransferases; Pyrimidine Nucleosides; Thymidine; Thymidine Kinase | 1987 |
2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
Topics: Animals; Antiviral Agents; Deoxycytidine; Deoxycytosine Nucleotides; HIV; Humans; Leukemia L1210; Mice; Phosphorylation; Pyrimidine Nucleosides; Pyrimidine Nucleotides; Pyrimidines; Thymidine; Tritium; Tumor Cells, Cultured; Zalcitabine | 1987 |
Rapid determination of thymidylate synthase activity and its inhibition in intact L1210 leukemia cells in vitro.
Topics: Animals; Cells, Cultured; Deoxycytidine; Deoxyuridine; Dose-Response Relationship, Drug; Floxuridine; Leukemia L1210; Methotrexate; Methyltransferases; Mice; Thymidylate Synthase; Tritium | 1985 |
Radical deoxygenation of tert-alcohols in 2'-branched-chain sugar pyrimidine nucleosides: synthesis and antileukemic activity of 2'-deoxy-2' (S)-methylcytidine.
Topics: Alcohols; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Deoxycytidine; Leukemia L1210; Mice; Tumor Cells, Cultured | 1987 |
2,6-Diaminopurinedeoxyriboside as a prodrug of deoxyguanosine in L1210 cells.
Topics: 2-Aminopurine; Adenosine Deaminase Inhibitors; Animals; Cell Division; Chromatography, High Pressure Liquid; Deoxyadenosines; Deoxycytidine; Deoxyguanosine; DNA Replication; Dose-Response Relationship, Drug; Leukemia L1210; Ribonucleotide Reductases | 1987 |
In vitro and in vivo studies of a promising antileukemic thymidine analogue, 5-hydroxymethyl-2' deoxyuridine.
Topics: Animals; Antineoplastic Agents; Blood Platelets; Cell Line; Deoxycytidine; Humans; Leukemia; Leukemia L1210; Thymidine | 1986 |
Enhancement of the anticancer activity of bis(2-chloroethyl)nitrosourea in mice by coadministration of 2'-deoxyuridine, 2'-deoxycytidine, or thymidine.
Topics: Animals; Carmustine; Deoxycytidine; Deoxyribonucleosides; Deoxyuridine; Drug Synergism; Leukemia L1210; Melanoma, Experimental; Mice; Ribonucleosides; Thymidine | 1987 |
Effect of the dialdehyde derivative of 5'-deoxyinosine on pyrimidine deoxyribonucleoside metabolism in L1210 cells.
Topics: Animals; Cells, Cultured; DCMP Deaminase; Deoxycytidine; Deoxyuridine; Inosine; Leukemia L1210; Mice; Thymidylate Synthase | 1985 |
Role of thymidylate synthetase in the cytostatic activity of pyrimidine nucleoside analogues.
Topics: Animals; Antineoplastic Agents; Arabinofuranosyluracil; Cytarabine; Deoxycytidine; Deoxyuridine; Leukemia L1210; Mice; Pyrimidine Nucleosides; Thymidylate Synthase | 1985 |
5-Fluorouracil and derivatives in cancer chemotherapy. 3. In vivo enhancement of antitumor activity of 5-fluorouracil (FU) and 5-fluoro-2'-deoxyuridine (FUDR).
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chromatography, Thin Layer; Deoxycytidine; Deoxyuridine; Dialysis; Drug Synergism; Drug Therapy, Combination; Floxuridine; Fluorouracil; Leukemia L1210; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Homologous | 1973 |
Cytidine 5'-triphosphate synthetase as a target for inhibition by the antitumor agent 3-deazauridine.
Topics: Animals; Cells, Cultured; Cytidine; Cytosine Nucleotides; Deoxycytidine; Deoxyuridine; Enzyme Inhibitors; Leukemia L1210; Ligases; Liver; Mice; Thymidine; Uracil Nucleotides; Uridine | 1974 |
Studies on the mode of action of 2,2'-anhydro-1- -D-arabinofuranosylcytosine.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Cell-Free System; Chromatography, Paper; Cytarabine; Deamination; Deoxycytidine; Drug Resistance; Electrophoresis, Paper; Escherichia coli; Female; Hydrogen-Ion Concentration; Hydrolysis; Leukemia L1210; Mice; Mice, Inbred Strains; Oxidative Phosphorylation | 1973 |